3.22.2 html 229 321 1 true 85 0 false 7 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 100010 - Statement - Consolidated Balance Sheets Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Consolidated Statements of Loss and Comprehensive Loss Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-consolidated-statements-of-loss-and-comprehensive-loss Consolidated Statements of Loss and Comprehensive Loss Statements 3 false false R4.htm 100030 - Statement - Consolidated Statements of Changes in Shareholder's Equity Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-consolidated-statements-of-changes-in-shareholders-equity Consolidated Statements of Changes in Shareholder's Equity Statements 4 false false R5.htm 100040 - Statement - Consolidated Statements of Cash Flows Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-consolidated-statements-of-cash-flows- Consolidated Statements of Cash Flows Statements 5 false false R6.htm 100050 - Disclosure - Note 1 - Nature of Operations Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-1-nature-of-operations Note 1 - Nature of Operations Notes 6 false false R7.htm 100060 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 7 false false R8.htm 100070 - Disclosure - Note 3 - Recent Accounting Pronouncements Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-3-recent-accounting-pronouncements Note 3 - Recent Accounting Pronouncements Notes 8 false false R9.htm 100080 - Disclosure - Note 4 - Acquisition of Grace Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote4AcquisitionOfGrace Note 4 - Acquisition of Grace Notes 9 false false R10.htm 100090 - Disclosure - Note 5 - Receivables Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote5Receivables1 Note 5 - Receivables Notes 10 false false R11.htm 100100 - Disclosure - Note 6 - Short-term Investments Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote6ShorttermInvestments Note 6 - Short-term Investments Notes 11 false false R12.htm 100110 - Disclosure - Note 7 - Impairment Loss Intangible Assets Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote7ImpairmentLossIntangibleAssets Note 7 - Impairment Loss Intangible Assets Notes 12 false false R13.htm 100120 - Disclosure - Note 8 - Assets Held for Sale Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote8AssetsHeldForSale Note 8 - Assets Held for Sale Notes 13 false false R14.htm 100130 - Disclosure - Note 9 - Government Assistance Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote9GovernmentAssistance1 Note 9 - Government Assistance Notes 14 false false R15.htm 100140 - Disclosure - Note 10 - Trade and Other Payables Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote10TradeAndOtherPayables Note 10 - Trade and Other Payables Notes 15 false false R16.htm 100150 - Disclosure - Note 11 - Derivative Warrant Liabilities Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote11DerivativeWarrantLiabilities Note 11 - Derivative Warrant Liabilities Notes 16 false false R17.htm 100170 - Disclosure - Note 12 - Capital and Other Components of Equity Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-12-capital-and-other-components-of-equity Note 12 - Capital and Other Components of Equity Notes 17 false false R18.htm 100180 - Disclosure - Note 13 - Revenues Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-13-revenues Note 13 - Revenues Notes 18 false false R19.htm 100190 - Disclosure - Note 14 - Net Financial Income (expenses) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote14NetFinancialIncomeExpenses Note 14 - Net Financial Income (expenses) Notes 19 false false R20.htm 100200 - Disclosure - Note 15 - Stock Based Compensation Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-15-stock-based-compensation Note 15 - Stock Based Compensation Notes 20 false false R21.htm 100210 - Disclosure - Note 16 - Loss Per Share Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-16-loss-per-share Note 16 - Loss Per Share Notes 21 false false R22.htm 100220 - Disclosure - Note 17 - Supplemental Cash Flow Disclosure Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-17-supplemental-cash-flow-disclosure Note 17 - Supplemental Cash Flow Disclosure Notes 22 false false R23.htm 100240 - Disclosure - Note 19 - Financial Instruments Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-19-financial-instruments Note 19 - Financial Instruments Notes 23 false false R24.htm 100250 - Disclosure - Note 20 - Commitments and Contingencies Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote20CommitmentsAndContingencies Note 20 - Commitments and Contingencies Notes 24 false false R25.htm 100260 - Disclosure - Note 21 - Subsequent Events Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-21-subsequent-events- Note 21 - Subsequent Events Notes 25 false false R26.htm 100270 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.acastipharma.com/20220331/taxonomy/role/statement-note-2-summary-of-significant-accounting-policies 26 false false R27.htm 100280 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Tables http://www.acastipharma.com/20220331/taxonomy/role/statement-note-2-summary-of-significant-accounting-policies 27 false false R28.htm 100290 - Disclosure - Note 4 - Acquisition of Grace (Tables) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote4AcquisitionOfGraceTables Note 4 - Acquisition of Grace (Tables) Tables http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote4AcquisitionOfGrace 28 false false R29.htm 100300 - Disclosure - Note 5 - Receivables (Tables) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote5ReceivablesTables Note 5 - Receivables (Tables) Tables http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote5Receivables1 29 false false R30.htm 100310 - Disclosure - Note 6 - Short-term Investments (Tables) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote6ShorttermInvestmentsTables Note 6 - Short-term Investments (Tables) Tables http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote6ShorttermInvestments 30 false false R31.htm 100320 - Disclosure - Note 8 - Assets Held for Sale (Tables) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote8AssetsHeldForSaleTables Note 8 - Assets Held for Sale (Tables) Tables http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote8AssetsHeldForSale 31 false false R32.htm 100330 - Disclosure - Note 9 - Government Assistance (Tables) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote9GovernmentAssistanceTables Note 9 - Government Assistance (Tables) Tables http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote9GovernmentAssistance1 32 false false R33.htm 100340 - Disclosure - Note 10 - Trade and Other Payables (Tables) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote10TradeAndOtherPayablesTables Note 10 - Trade and Other Payables (Tables) Tables http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote10TradeAndOtherPayables 33 false false R34.htm 100350 - Disclosure - Note 11 - Derivative Warrant Liabilities (Tables) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote11DerivativeWarrantLiabilitiesTables Note 11 - Derivative Warrant Liabilities (Tables) Tables http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote11DerivativeWarrantLiabilities 34 false false R35.htm 100370 - Disclosure - Note 12 - Capital and Other Components of Equity (Tables) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-12-capital-and-other-components-of-equity-tables Note 12 - Capital and Other Components of Equity (Tables) Tables http://www.acastipharma.com/20220331/taxonomy/role/statement-note-12-capital-and-other-components-of-equity 35 false false R36.htm 100380 - Disclosure - Note 14 - Net Financial Expenses (Tables) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote14NetFinancialExpensesTables Note 14 - Net Financial Expenses (Tables) Tables 36 false false R37.htm 100390 - Disclosure - Note 15 - Stock Based Compensation (Tables) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-15-stock-based-compensation-tables Note 15 - Stock Based Compensation (Tables) Tables http://www.acastipharma.com/20220331/taxonomy/role/statement-note-15-stock-based-compensation 37 false false R38.htm 100400 - Disclosure - Note 17 - Supplemental Cash Flow Disclosure (Tables) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-17-supplemental-cash-flow-disclosure-tables Note 17 - Supplemental Cash Flow Disclosure (Tables) Tables http://www.acastipharma.com/20220331/taxonomy/role/statement-note-17-supplemental-cash-flow-disclosure 38 false false R39.htm 100410 - Disclosure - Note 18 - Income Taxes (Tables) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-18-income-taxes-tables Note 18 - Income Taxes (Tables) Tables 39 false false R40.htm 100420 - Disclosure - Note 1 - Nature of Operation (Details Textual) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote1NatureOfOperationDetailsTextual Note 1 - Nature of Operation (Details Textual) Details http://www.acastipharma.com/20220331/taxonomy/role/statement-note-1-nature-of-operations 40 false false R41.htm 100430 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://www.acastipharma.com/20220331/taxonomy/role/statement-note-2-summary-of-significant-accounting-policies-tables 41 false false R42.htm 100440 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Estimated Useful Lives and Rates of Equipment (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-2-summary-of-significant-accounting-policies-estimated-useful-lives-and-rates-of-equipment-details Note 2 - Summary of Significant Accounting Policies - Estimated Useful Lives and Rates of Equipment (Details) Details 42 false false R43.htm 100450 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Estimated Useful Lives of Intangible Assets (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-2-summary-of-significant-accounting-policies-estimated-useful-lives-of-intangible-assets-details Note 2 - Summary of Significant Accounting Policies - Estimated Useful Lives of Intangible Assets (Details) Details 43 false false R44.htm 100460 - Disclosure - Note 4 - Acquisition of Grace - Consideration (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote4AcquisitionOfGraceConsiderationDetails Note 4 - Acquisition of Grace - Consideration (Details) Details 44 false false R45.htm 100470 - Disclosure - Note 4 - Acquisition of Grace - Assets Acquired and Liabilities Assumed (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote4AcquisitionOfGraceAssetsAcquiredAndLiabilitiesAssumedDetails Note 4 - Acquisition of Grace - Assets Acquired and Liabilities Assumed (Details) Details 45 false false R46.htm 100480 - Disclosure - Note 4 - Acquisition of Grace - Pro Forma Financial Information (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote4AcquisitionOfGraceProFormaFinancialInformationDetails Note 4 - Acquisition of Grace - Pro Forma Financial Information (Details) Details 46 false false R47.htm 100490 - Disclosure - Note 4 - Acquisition of Grace - Schedule of Intangible Assets in Process Research and Development (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote4AcquisitionOfGraceScheduleOfIntangibleAssetsInProcessResearchAndDevelopmentDetails Note 4 - Acquisition of Grace - Schedule of Intangible Assets in Process Research and Development (Details) Details 47 false false R48.htm 100500 - Disclosure - Note 4 - Acquisition of Grace (Details Textual) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote4AcquisitionOfGraceDetailsTextual Note 4 - Acquisition of Grace (Details Textual) Details http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote4AcquisitionOfGraceTables 48 false false R49.htm 100510 - Disclosure - Note 5 - Receivables - Receivables (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote5ReceivablesReceivablesDetails Note 5 - Receivables - Receivables (Details) Details 49 false false R50.htm 100520 - Disclosure - Note 6 - Short-term Investments - Marketable Securities (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote6ShorttermInvestmentsMarketableSecuritiesDetails Note 6 - Short-term Investments - Marketable Securities (Details) Details 50 false false R51.htm 100530 - Disclosure - Note 6 - Short-term Investments - Marketable Securities (Details) (Parentheticals) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote6ShorttermInvestmentsMarketableSecuritiesDetailsParentheticals Note 6 - Short-term Investments - Marketable Securities (Details) (Parentheticals) Details 51 false false R52.htm 100540 - Disclosure - Note 7 - Impairment Loss Intangible Assets (Details Textual) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote7ImpairmentLossIntangibleAssetsDetailsTextual Note 7 - Impairment Loss Intangible Assets (Details Textual) Details http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote7ImpairmentLossIntangibleAssets 52 false false R53.htm 100550 - Disclosure - Note 8 - Assets Held for Sale (Details Textual) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote8AssetsHeldForSaleDetailsTextual Note 8 - Assets Held for Sale (Details Textual) Details http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote8AssetsHeldForSaleTables 53 false false R54.htm 100560 - Disclosure - Note 8 - Assets Held for Sale - Summary of Assets Held for Sale (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote8AssetsHeldForSaleSummaryOfAssetsHeldForSaleDetails Note 8 - Assets Held for Sale - Summary of Assets Held for Sale (Details) Details 54 false false R55.htm 100570 - Disclosure - Note 9 - Government Assistance (Details Textual) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote9GovernmentAssistanceDetailsTextual Note 9 - Government Assistance (Details Textual) Details http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote9GovernmentAssistanceTables 55 false false R56.htm 100580 - Disclosure - Note 9 - Government Assistance - Government Assistance (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote9GovernmentAssistanceGovernmentAssistanceDetails Note 9 - Government Assistance - Government Assistance (Details) Details 56 false false R57.htm 100590 - Disclosure - Note 9 - Government Assistance - Unrecognized Federal Tax Credits Expirations (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote9GovernmentAssistanceUnrecognizedFederalTaxCreditsExpirationsDetails Note 9 - Government Assistance - Unrecognized Federal Tax Credits Expirations (Details) Details 57 false false R58.htm 100600 - Disclosure - Note 10 - Trade and Other Payables - Trade and Other Payables (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote10TradeAndOtherPayablesTradeAndOtherPayablesDetails Note 10 - Trade and Other Payables - Trade and Other Payables (Details) Details 58 false false R59.htm 100610 - Disclosure - Note 11 - Derivative Warrant Liabilities (Details Textual) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote11DerivativeWarrantLiabilitiesDetailsTextual Note 11 - Derivative Warrant Liabilities (Details Textual) Details http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote11DerivativeWarrantLiabilitiesTables 59 false false R60.htm 100620 - Disclosure - Note 11 - Derivative Warrant Liabilities - Changes in Fair Value (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote11DerivativeWarrantLiabilitiesChangesInFairValueDetails Note 11 - Derivative Warrant Liabilities - Changes in Fair Value (Details) Details 60 false false R61.htm 100630 - Disclosure - Note 11 - Derivative Warrant Liabilities - Assumptions (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote11DerivativeWarrantLiabilitiesAssumptionsDetails Note 11 - Derivative Warrant Liabilities - Assumptions (Details) Details 61 false false R62.htm 100660 - Disclosure - Note 12 - Capital and Other Components of Equity (Details Textual) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-12-capital-and-other-components-of-equity-details-textual Note 12 - Capital and Other Components of Equity (Details Textual) Details http://www.acastipharma.com/20220331/taxonomy/role/statement-note-12-capital-and-other-components-of-equity-tables 62 false false R63.htm 100670 - Disclosure - Note 12 - Capital and Other Components of Equity - Warrants (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-12-capital-and-other-components-of-equity-warrants-details Note 12 - Capital and Other Components of Equity - Warrants (Details) Details http://www.acastipharma.com/20220331/taxonomy/role/statement-note-12-capital-and-other-components-of-equity-tables 63 false false R64.htm 100680 - Disclosure - Note 14 - Net Financial Expenses - Financial Income (Expenses) (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote14NetFinancialExpensesFinancialIncomeExpensesDetails Note 14 - Net Financial Expenses - Financial Income (Expenses) (Details) Details 64 false false R65.htm 100690 - Disclosure - Note 15 - Stock Based Compensation (Details Textual) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-15-stock-based-compensation-details-textual Note 15 - Stock Based Compensation (Details Textual) Details http://www.acastipharma.com/20220331/taxonomy/role/statement-note-15-stock-based-compensation-tables 65 false false R66.htm 100700 - Disclosure - Note 15 - Stock-based Compensation - Activities Within the Stock Option Plan (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-15-stockbased-compensation-activities-within-the-stock-option-plan-details Note 15 - Stock-based Compensation - Activities Within the Stock Option Plan (Details) Details 66 false false R67.htm 100710 - Disclosure - Note 15 - Stock Based Compensation - Compensation Expense (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-15-stock-based-compensation-compensation-expense-details Note 15 - Stock Based Compensation - Compensation Expense (Details) Details 67 false false R68.htm 100720 - Disclosure - Note 15 - Stock-based Compensation - Summary of the non-vested stock option activity (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote15StockbasedCompensationSummaryOfTheNonvestedStockOptionActivityDetails Note 15 - Stock-based Compensation - Summary of the non-vested stock option activity (Details) Details 68 false false R69.htm 100730 - Disclosure - Note 15 - Stock-based Compensation - Assumptions (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-15-stockbased-compensation-assumptions-details Note 15 - Stock-based Compensation - Assumptions (Details) Details 69 false false R70.htm 100740 - Disclosure - Note 15 - Stock-based Compensation - Outstanding and Exercisable Options (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-15-stockbased-compensation-outstanding-and-exercisable-options-details Note 15 - Stock-based Compensation - Outstanding and Exercisable Options (Details) Details 70 false false R71.htm 100750 - Disclosure - Note 17 - Supplemental Cash Flow Disclosure - Changes in Working Capital Items (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-17-supplemental-cash-flow-disclosure-changes-in-working-capital-items-details Note 17 - Supplemental Cash Flow Disclosure - Changes in Working Capital Items (Details) Details 71 false false R72.htm 100770 - Disclosure - Note 18 - Income taxes - Income Tax (Recovery) Expense (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote18IncomeTaxesIncomeTaxRecoveryExpenseDetails Note 18 - Income taxes - Income Tax (Recovery) Expense (Details) Details 72 false false R73.htm 100780 - Disclosure - Note 18 - Income Taxes - Reconciliation of Effective Tax Rate (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-18-income-taxes-reconciliation-of-effective-tax-rate-details Note 18 - Income Taxes - Reconciliation of Effective Tax Rate (Details) Details 73 false false R74.htm 100790 - Disclosure - Note 18 - Income Taxes - Net Deferred Tax Assets (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-18-income-taxes-net-deferred-tax-assets-details Note 18 - Income Taxes - Net Deferred Tax Assets (Details) Details 74 false false R75.htm 100800 - Disclosure - Note 18 - Income Taxes - Tax Attributes and Temporary Differences Available to Reduce Future Years' Taxable Income (Details) Sheet http://www.acastipharma.com/20220331/taxonomy/role/statement-note-18-income-taxes-tax-attributes-and-temporary-differences-available-to-reduce-future-years-taxable-income-details Note 18 - Income Taxes - Tax Attributes and Temporary Differences Available to Reduce Future Years' Taxable Income (Details) Details 75 false false R76.htm 100820 - Disclosure - Note 20 - Commitments and Contingencies (Details Textual) Sheet http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote20CommitmentsAndContingenciesDetailsTextual Note 20 - Commitments and Contingencies (Details Textual) Details http://www.acastipharma.com/20220331/taxonomy/role/DisclosureNote20CommitmentsAndContingencies 76 false false R77.htm 100830 - Disclosure - 21. Subsequent events (Additional Information) (Details Textual) Sheet http://www.acastipharma.com/20220331/taxonomy/role/Disclosure21SubsequentEventsAdditionalInformationDetailsTextual 21. Subsequent events (Additional Information) (Details Textual) Details 77 false false All Reports Book All Reports acst-20220331.htm acst-20220331.xsd acst-20220331_cal.xml acst-20220331_def.xml acst-20220331_lab.xml acst-20220331_pre.xml acst-ex10_3.htm acst-ex10_6.htm acst-ex23_1.htm acst-ex31_1.htm acst-ex31_2.htm acst-ex32_1.htm acst-ex32_2.htm acst-ex4_6.htm img179493417_0.jpg img179493417_1.jpg img179493417_10.jpg img179493417_11.jpg img179493417_12.jpg img179493417_13.jpg img179493417_14.jpg img179493417_15.jpg img179493417_2.jpg img179493417_3.jpg img179493417_4.jpg img179493417_5.jpg img179493417_6.jpg img179493417_7.jpg img179493417_8.jpg img179493417_9.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true